These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 20172138)

  • 1. Engraftment is optimal when myoblasts are transplanted early: the role of hepatocyte growth factor.
    O'Blenes SB; Li AW; Chen R; Arora RC; Horackova M
    Ann Thorac Surg; 2010 Mar; 89(3):829-35. PubMed ID: 20172138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of hepatocyte growth factor on skeletal myoblast transplantation late after myocardial infarction.
    O'Blenes SB; Li AW; Bowen C; Debay D; Althobaiti M; Clarke J
    Drug Target Insights; 2013; 7():9-17. PubMed ID: 23700363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined autologous cellular cardiomyoplasty with skeletal myoblasts and bone marrow cells in canine hearts for ischemic cardiomyopathy.
    Memon IA; Sawa Y; Miyagawa S; Taketani S; Matsuda H
    J Thorac Cardiovasc Surg; 2005 Sep; 130(3):646-53. PubMed ID: 16153908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular, but not direct, adenoviral delivery of vascular endothelial growth factor results in improved left ventricular function and neovascularization in dilated ischemic cardiomyopathy.
    Askari A; Unzek S; Goldman CK; Ellis SG; Thomas JD; DiCorleto PE; Topol EJ; Penn MS
    J Am Coll Cardiol; 2004 May; 43(10):1908-14. PubMed ID: 15145120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of the functional benefits of skeletal myoblast transplantation by means of coadministration of hypoxia-inducible factor 1alpha.
    Azarnoush K; Maurel A; Sebbah L; Carrion C; Bissery A; Mandet C; Pouly J; Bruneval P; Hagège AA; Menasché P
    J Thorac Cardiovasc Surg; 2005 Jul; 130(1):173-9. PubMed ID: 15999059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene transfection with human hepatocyte growth factor complementary DNA plasmids attenuates cardiac remodeling after acute myocardial infarction in goat hearts implanted with ventricular assist devices.
    Shirakawa Y; Sawa Y; Takewa Y; Tatsumi E; Kaneda Y; Taenaka Y; Matsuda H
    J Thorac Cardiovasc Surg; 2005 Sep; 130(3):624-32. PubMed ID: 16153905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of transplanted myoblasts transfected with human growth hormone gene on improvement of ventricular function of rats.
    Rong SL; Lu YX; Liao YH; Wang XL; Wang YJ; Chang C; Wang YQ; Liu QY; Gao YZ; Mi SH
    Chin Med J (Engl); 2008 Feb; 121(4):347-54. PubMed ID: 18304469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of angiogenesis and inhibition of apoptosis by hepatocyte growth factor effectively treats postischemic heart failure.
    Jayasankar V; Woo YJ; Pirolli TJ; Bish LT; Berry MF; Burdick J; Gardner TJ; Sweeney HL
    J Card Surg; 2005; 20(1):93-101. PubMed ID: 15673421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental study of bone marrow-derived mesenchymal stem cells combined with hepatocyte growth factor transplantation via noninfarct-relative artery in acute myocardial infarction.
    Yang ZJ; Ma DC; Wang W; Xu SL; Zhang YQ; Chen B; Zhou F; Zhu TB; Wang LS; Xu ZQ; Zhang FM; Cao KJ; Ma WZ
    Gene Ther; 2006 Nov; 13(22):1564-8. PubMed ID: 16810195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrophysiological consequence of skeletal myoblast transplantation in normal and infarcted canine myocardium.
    Fouts K; Fernandes B; Mal N; Liu J; Laurita KR
    Heart Rhythm; 2006 Apr; 3(4):452-61. PubMed ID: 16567294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stem cell therapy enhances electrical viability in myocardial infarction.
    Mills WR; Mal N; Kiedrowski MJ; Unger R; Forudi F; Popovic ZB; Penn MS; Laurita KR
    J Mol Cell Cardiol; 2007 Feb; 42(2):304-14. PubMed ID: 17070540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early treatment with hepatocyte growth factor improves cardiac function in experimental heart failure induced by myocardial infarction.
    Jin H; Yang R; Li W; Ogasawara AK; Schwall R; Eberhard DA; Zheng Z; Kahn D; Paoni NF
    J Pharmacol Exp Ther; 2003 Feb; 304(2):654-60. PubMed ID: 12538818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postinfarction treatment with an adenoviral vector expressing hepatocyte growth factor relieves chronic left ventricular remodeling and dysfunction in mice.
    Li Y; Takemura G; Kosai K; Yuge K; Nagano S; Esaki M; Goto K; Takahashi T; Hayakawa K; Koda M; Kawase Y; Maruyama R; Okada H; Minatoguchi S; Mizuguchi H; Fujiwara T; Fujiwara H
    Circulation; 2003 May; 107(19):2499-506. PubMed ID: 12695295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor transgene expression in cell-transplanted hearts.
    Yau TM; Li G; Weisel RD; Reheman A; Jia ZQ; Mickle DA; Li RK
    J Thorac Cardiovasc Surg; 2004 Apr; 127(4):1180-7. PubMed ID: 15052220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of collateral artery growth and improvement of post-infarct heart function by hepatocyte growth factor gene transfer.
    Wang W; Yang ZJ; Ma DC; Wang LS; Xu SL; Zhang YR; Cao KJ; Zhang FM; Ma WZ
    Acta Pharmacol Sin; 2006 May; 27(5):555-60. PubMed ID: 16626510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocyte growth factor-transfected skeletal myoblasts to limit the development of postinfarction heart failure.
    Poppe A; Golsong P; Blumenthal B; von Wattenwyl R; Blanke P; Beyersdorf F; Schlensak C; Siepe M
    Artif Organs; 2012 Mar; 36(3):238-46. PubMed ID: 21899570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous versus surgical delivery of autologous myoblasts after chronic myocardial infarction: an in vivo cardiovascular magnetic resonance study.
    Larose E; Proulx G; Voisine P; Rodés-Cabau J; De Larochellière R; Rossignol G; Bertrand OF; Tremblay JP
    Catheter Cardiovasc Interv; 2010 Jan; 75(1):120-7. PubMed ID: 19859959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocyte growth factor and granulocyte colony-stimulating factor form a combined neovasculogenic therapy for ischemic cardiomyopathy.
    Guo YH; He JG; Wu JL; Yang L; Zhang DS; Tan XY; Qi RD
    Cytotherapy; 2008; 10(8):857-67. PubMed ID: 18956268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologically preconditioned skeletal myoblasts are resistant to oxidative stress and promote angiomyogenesis via release of paracrine factors in the infarcted heart.
    Niagara MI; Haider HKh; Jiang S; Ashraf M
    Circ Res; 2007 Mar; 100(4):545-55. PubMed ID: 17234963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene transfer of hepatocyte growth factor attenuates postinfarction heart failure.
    Jayasankar V; Woo YJ; Bish LT; Pirolli TJ; Chatterjee S; Berry MF; Burdick J; Gardner TJ; Sweeney HL
    Circulation; 2003 Sep; 108 Suppl 1():II230-6. PubMed ID: 12970238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.